Matthew Myntti
Founder presso NEXT SCIENCE LIMITED
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Matthew Myntti is the founder of Next Science Ltd.
which was founded in 2017, where he holds the title of Chief Technology Officer.
He is currently a Director at Microbial Defense System Holdings, Inc. since 2012.
He previously worked at Synthes GmbH as the President-Asia Pacific.
Dr. Myntti received his undergraduate and doctorate degrees from the University of Dayton.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NEXT SCIENCE LTD
3.59% | 14/03/2023 | 10 472 969 ( 3.59% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Matthew Myntti
| Società | Posizione | Inizio |
|---|---|---|
| NEXT SCIENCE LIMITED | Founder | 20/10/2017 |
Microbial Defense System Holdings, Inc.
 Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Director/Board Member | 30/03/2012 |
Precedenti posizioni note di Matthew Myntti
| Società | Posizione | Fine |
|---|---|---|
Synthes GmbH
 Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Corporate Officer/Principal | - |
Formazione di Matthew Myntti
| University of Dayton | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEXT SCIENCE LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Finance |
- Borsa valori
- Insiders
- Matthew Myntti
